Investing.com - Financial Markets Worldwide
🔮 Better than the Oracle? Our Fair Value found this +42% bagger 5 months before Buffett bought itRead More

China Botanic Pharmaceutical Ready To Take Off?

ByDutch Trader
Published 02/02/2012, 02:40 AM
Updated 07/09/2023, 06:31 AM
2070
-

China Botanic Pharmaceutical (CBP) is heavy undervalued with a P/E (Price/Earnings ratio) below 2. Despite that, investors still seem to be afraid of the unknown. The fraud risk in this company is low in my opinion.

With the appointment of Mr. Zack Zibing Pan to its Board of Directors on October 15, 2011 they got a heavyweight in their ranks. Mr. Pan is now independent director and chairman of the Audit Committee, and a member of the Nomination and Compensation Committee.

Mr. Pan is a Certified Public Accountant, certified by the Oklahoma State Board of Accountancy. He is also a member of the American Institute of Certified Public Accountants (AICPA) and the Oklahoma Society of Certified Public Accountants (OSCPA). Mr. Pan graduated with a Master of Business Administration from the University of Central Oklahoma in 1999. He obtained his Bachelor of Arts from Anhui University, China in 1988.

"We are delighted and honored to welcome Mr. Pan to our board," said Mr. Shaoming Li, Chairman and Chief Executive Officer of China Botanic. "We are looking forward to working with Mr. Pan and believe that he will help enhance China Botanics' corporate governance and bring his industry and finance expertise to the Board. We believe that the appointment of high-caliber directors to our Board underscores our commitment to corporate governance and integrity."

The fact that it still has some institutional holders gives me faith that Good Times Could Occur In The Nearby Future.

6 Institutional Holders

Latest comments

Loading next article…
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.